Darunavir / Cobicistat 800 mg/150 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 800 mg/150 mg
Reference Brands: Prezcobix (USA/EU)
Category: Anti Viral
Darunavir / Cobicistat is a Anti Viral product available as Tablets in strengths 800 mg/150 mg. It corresponds to the reference brand Prezcobix (USA/EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Darunavir/cobicistat is a fixed-dose combination antiretroviral medication used for the treatment and prevention of HIV-1 infection. It is marketed under the brand name Prezcobix in the USA and Rezolsta in the EU. This combination contains darunavir, an HIV protease inhibitor that blocks viral replication, and cobicistat, a pharmacokinetic enhancer that increases the effectiveness of darunavir by inhibiting its metabolism through the CYP3A enzyme.
Darunavir/cobicistat 800 mg/150 mg tablets are indicated for use in both treatment-naive and treatment-experienced adult patients who do not have darunavir resistance-associated mutations. When administered as part of combination antiretroviral therapy, it helps to suppress viral load, maintain immune function, and reduce the risk of HIV-related complications.
The fixed-dose combination provides convenient once-daily dosing, improving adherence to therapy. Its efficacy in combination with other antiretrovirals has been well documented, making it a cornerstone option in modern HIV management. The combination is available as oral tablets in strengths suitable for both initial and ongoing therapy, offering patients a safe and effective treatment option with proven clinical benefits.
Darunavir / Cobicistat — third party manufacturing & bulk supply
Darunavir / Cobicistat 800 mg/150 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Darunavir / Cobicistat is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Darunavir / Cobicistat listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Darunavir / Cobicistat →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Darunavir / Cobicistat is used to treat HIV-1 infection in adults by suppressing viral replication and maintaining immune function.
It is a combination of darunavir, a protease inhibitor, and cobicistat, a pharmacokinetic enhancer that increases darunavir’s effectiveness.
The trade name is Prezcobix.
Darunavir / Cobicistat is marketed by Janssen Pharmaceuticals, part of Johnson & Johnson.
The generic name is darunavir / cobicistat.
The brand name is Prezcobix.
It is manufactured in approved pharmaceutical facilities in the USA, EU, and UK.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View Details
Lenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
